XTENT Inc. (XTNT) is a BUY
XTENT, Inc. today announced that the Company received conditional approval from the United States Food and Drug Administration (FDA) for an Investigational Device Exemption (IDE) authorizing it to begin its pivotal clinical program, composed of two pivotal trials called CUSTOM IV and CUSTOM IV Angio to support the approval in the United States of its Custom NX Drug Eluting Stent (DES) System.
More: continued here
Tags: Ex, FDA, Food, Food and Drug Administration, States, United States, US